Denver's women-only program for mental health, trauma and substance use.Call Admissions 833.754.0554
Call 833.754.0554Verify Insurance
A mobile phone beside an armchair and softly lit lamp.
Women’s Recovery · Blog

Suicide Risk as Stimulants Wear Off: Why It Can Rise

Learn why suicide risk as stimulants wear off needs active assessment, why a calmer appearance can mislead, and when to contact 988 or call 911.

Suicide risk as stimulants wear off can rise even when someone seems less agitated. The ASAM/AAAP stimulant guideline warns that suicidal thoughts may increase during fading intoxication and acute withdrawal. That change calls for active assessment, not an assumption that the danger has passed. See Recommendation 62.

A stimulant crash is a common name for the difficult period after stimulant effects fade. It is not a safety assessment. The same person can have different needs during active intoxication, fading intoxication, and withdrawal. For a woman experiencing this change, or someone worried about her, the key issue is current safety rather than how much time has passed. Clinicians need to consider changes in mood, thinking, physical health, and risk of self-harm together. The ASAM/AAAP guideline recommends monitoring these changing concerns and choosing a care setting able to respond.

Why can safety concerns change as stimulant intoxication fades?

Fading stimulant effects do not mean that every risk is fading with them. This distinction matters in both substance-use care and ongoing treatment for stimulant use disorder: the immediate safety picture can change before longer-term treatment begins. The ASAM/AAAP guideline, Recommendation 62, specifically warns that suicidality may increase during waning intoxication and acute withdrawal.

Waning intoxication means that the drug’s intoxicating effects are diminishing. Acute withdrawal is the early withdrawal period after use stops or decreases. These are clinical phases, not precise time slots that a loved one can reliably identify by watching the clock. The guideline directs clinicians to consider the phase of stimulant use when evaluating depression, anxiety, sleep problems, and other symptoms.

Someone may become less visibly restless while feeling more distressed internally. That is why a decrease in one outward symptom cannot establish that the person is safe. Physical observations and a direct mental-health assessment answer different parts of the safety question.

The guideline also notes that alcohol, opioids, or other sedatives taken alongside stimulants can change the course and severity of intoxication in unexpected ways. A simple explanation such as “the stimulant is wearing off” may therefore miss other medical or psychiatric needs. Assessment must address the whole current presentation, rather than assume one drug explains every change. See the guideline’s setting-determination discussion.

Why should suicidal thoughts never be dismissed as only a crash?

Suicidal thoughts need prompt attention even when they appear closely linked to stimulant use. Emergency care and outpatient treatment serve different purposes, while ongoing substance-use treatment addresses needs beyond the immediate crisis. The ASAM/AAAP guideline’s suicidality section recommends psychiatric consultation and a safety assessment when suicide risk is present.

The word “crash” can describe a difficult experience, but it does not establish how severe that experience is. It cannot tell you that suicidal thoughts are harmless, that someone can remain safe without professional help, or that the thoughts will resolve within a particular number of hours.

There is also a difference between explaining a symptom and deciding how urgently to treat it. A clinician may consider stimulant withdrawal a possible cause of depression while still treating that depression as a serious concern. Recommendation 24 advises clinicians to consider treatment based on symptom severity and duration, even when symptoms are stimulant induced. A drug-related cause does not cancel the need for care.

The evidence has limits worth understanding. The guideline committee reported finding no studies specifically on managing suicidality during stimulant intoxication or withdrawal. Its recommendations draw on established suicide-care practices and clinical judgment. This supports careful assessment and monitoring, not a claim that every withdrawal episode follows the same pattern or that a specific recovery timeline guarantees safety.

What does active clinical monitoring involve during withdrawal?

Active monitoring means reassessing changing symptoms and responding when the person’s needs change. It is different from waiting for the next appointment within scheduled outpatient care or assuming that a personal safety plan replaces clinical assessment. The ASAM/AAAP guideline, Recommendations 45–54 and 62, describes assessment, monitoring, and decisions about the appropriate care setting.

A clinical review includes physical health and mental state. Stimulant intoxication can involve serious medical complications, while withdrawal can involve psychiatric symptoms that also need attention. The first priority is identifying urgent concerns that require a more intensive setting.

  • Current risk of harm: Clinicians assess suicidality and risk of harm to the person or others.
  • Changes in thinking and behavior: Confusion, psychosis, agitation, and other psychiatric changes affect the safety picture.
  • Physical signs: Heart rate, blood pressure, temperature, and other findings help identify medical complications.
  • Other substances and health conditions: Co-occurring conditions and substances taken together can affect the course of care.

The guideline recommends a validated suicide-assessment instrument, such as the Columbia–Suicide Severity Rating Scale, as part of evaluating suicidality. This is a structured clinical tool, not a substitute for a qualified professional’s assessment. A positive screen requires further attention to safety and the care setting.

Monitoring also requires the ability to act. A setting that cannot assess or manage worsening symptoms may need to arrange transfer to more intensive care. There is no universal monitoring schedule that a family can copy from an article. The frequency and setting depend on the person’s symptoms, risks, response to care, and available clinical resources.

Can a calmer appearance or a set timeline confirm safety?

No. Looking calmer and being clinically safe are different findings. A review of medical stability and outpatient fit and a current safety assessment concern more than outward behavior. The ASAM/AAAP guideline calls for monitoring psychiatric symptoms as intoxication fades, including the possible emergence or increase of suicidality.

It is understandable to feel relieved when someone stops pacing or seems less distressed. That observation can be useful, but it is only one piece of information. A person’s current thoughts and risk of harm still need attention. Improvement in agitation does not answer those questions.

A fixed “crash timeline” is not a safe substitute either. The guideline distinguishes several phases of stimulant use and withdrawal, and notes that some post-acute symptoms, including depression, anxiety, insomnia, and paranoia, can last for weeks to months. That does not mean suicidal thoughts will last that long. It means different symptoms can follow different courses and should be assessed on their own merits.

The committee also noted clinical experience suggesting that suicide risk can sometimes resolve more rapidly in stimulant withdrawal than in other withdrawal syndromes. That observation is not a waiting rule. It cannot predict an individual woman’s course or justify postponing help. Decisions about reducing monitoring or changing settings belong to the clinicians assessing her current condition.

For loved ones, the useful distinction is between noticing change and declaring the crisis over. You can share what you observe without having to make the final clinical judgment about safety.

When should you call 988 or call 911 immediately?

Call 911 for immediate danger, a suicide attempt, suspected overdose, or severe medical symptoms. Call or text 988 for suicidal thoughts or a mental-health crisis. NIAAA lists the 988 Suicide & Crisis Lifeline as available around the clock across the United States. The ASAM/AAAP guideline directs severe stimulant-related complications to acute care.

You do not need to establish whether the distress comes from withdrawal, another mental-health condition, or several causes before seeking crisis help. Immediate care is based on the danger and symptoms present now. Severe chest pain, a seizure, or dangerous overheating after stimulant use requires emergency attention rather than a routine treatment message.

Current concernAppropriate responseWhy waiting is not the right test
Immediate danger or a suicide attemptCall 911 immediately.Emergency assessment and protection may be needed now.
Suicidal thoughts or a mental-health crisisCall or text 988. Use 911 if danger is immediate.Crisis support can begin before the cause is clear.
Suspected overdose, seizure, severe chest pain, or dangerous overheatingCall 911 immediately.Stimulant-related medical complications can be life-threatening.
Ongoing care needs after immediate safety is addressedReconnect with the treating team or outpatient admissions.Routine treatment planning serves a different role from emergency care.

These distinctions follow ASAM/AAAP’s acute-care recommendations and Women’s Recovery’s emergency contact notice. A contact form, email, or unanswered routine phone message does not provide crisis monitoring.

  • Take the concern seriously: Do not dismiss suicidal thoughts because the person recently used a stimulant.
  • Use the appropriate help route: Do not wait for a scheduled visit when crisis or emergency help is needed.
  • Leave assessment to professionals: Loved ones should not have to decide alone whether withdrawal explains the danger.

How can treatment continue after immediate safety care?

Once immediate safety needs are addressed, treatment can reconnect through a fresh review of current needs and a clear handoff. Women’s Recovery’s outpatient programs address mental health, trauma, and substance use; its contact team can discuss possible next steps in Denver, CO. Women’s Recovery does not provide onsite detox, residential care, or inpatient treatment. Its outpatient programs do not replace emergency assessment.

The next care decision should reflect the condition the woman is in now. Becoming less intoxicated does not automatically establish readiness for outpatient treatment. The ASAM/AAAP guideline recommends addressing urgent concerns first, then completing a fuller assessment and treating co-occurring psychiatric conditions alongside stimulant use disorder.

A useful handoff carries forward the safety concerns identified, the symptoms that still need treatment, and who is responsible for the next stage of care. Continuing assessment matters because mood, sleep, and thinking can change after the immediate crisis. Ongoing treatment should make room for those changes rather than treat the emergency visit as the end of care.

Longer-term stimulant treatment also has a separate job: helping reduce stimulant use and supporting recovery. The guideline identifies contingency management as the current standard of care for stimulant use disorder. It reinforces agreed treatment behaviors with tangible rewards. That evidence does not make it an emergency suicide intervention or establish that a particular program offers it. Read more about contingency management for stimulant use disorder.

For a nonemergency conversation after safety care, call Women’s Recovery at 833.754.0554. You do not need to choose a program before contacting the team. Assessment guides whether an outpatient option can meet current needs.

Frequently asked questions

Does every stimulant withdrawal involve suicidal thoughts?

No. The ASAM/AAAP guideline warns that suicidality may increase as stimulant intoxication fades and during acute withdrawal; it does not say this happens to everyone. The warning supports routine assessment and attention to changing symptoms. Suicidal thoughts deserve prompt help even when they seem connected to a temporary crash.

Can appearing calmer mean that all safety concerns have passed?

No. Less visible agitation does not establish that suicide risk or other psychiatric concerns have resolved. The ASAM/AAAP guideline recommends monitoring for changing psychiatric symptoms, including suicidality, as intoxication fades. A clinician needs to assess the current safety picture rather than rely only on outward calm or elapsed time.

Should a loved one wait for the next scheduled treatment visit?

Not when suicidal thoughts, a mental-health crisis, or immediate danger are present. Call or text 988 for crisis support. Call 911 immediately for imminent danger, a suicide attempt, severe symptoms, or suspected overdose. A routine appointment or admissions message is not a substitute for urgent help.

Is an outpatient contact form an emergency resource?

No. Women’s Recovery states that its contact form is not monitored for emergencies. Use it for routine contact requests, not a suicide crisis or urgent medical concern. Call 911 for immediate danger, severe symptoms, or suspected overdose, and call or text 988 for a mental-health crisis.